-transparent.png){kind=logo}
The antitumor activity of a novel ansamycin antibiotic, trienomycin A, against various murine tumors was studied with two treatment schedules. The intraperitoneal injection of the antibiotic showed remarkable antitumor activity on sarcoma 180 and P388 leukemia at doses of 160 or 320 mg/kg, showing 151% and 100% increase in life span, respectively. Trienomycin A inhibited the growth of Ehrlich and Meth A cells in vitro at doses of 0.1-0.4 microgram/ml when the cells were exposed to the antibiotic for 72 hours. The incorporation of [3H]thymidine into acid precipitable material in HeLa cells was slightly more marked than that of [3H]uridine and [3H]leucine when the cells were exposed to 0.04 or 0.08 microgram/ml of trienomycin A for 4 hours. It appeared that trienomycin A showed antitumor activity by direct cytotoxic action.
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
January 1984,
Cancer chemotherapy and pharmacology,
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
January 1991,
Cancer chemotherapy and pharmacology,
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
September 1988,
The Journal of antibiotics,
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
January 1985,
Cancer chemotherapy and pharmacology,
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
October 1993,
The Journal of experimental medicine,
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
January 1982,
Cancer chemotherapy and pharmacology,
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
April 1981,
Gan,
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
December 1993,
Gan to kagaku ryoho. Cancer & chemotherapy,
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
March 1987,
Journal of pharmacobio-dynamics,
K Komiyama, and
Y Hirokawa, and
H Yamaguchi, and
S Funayama, and
K Masuda, and
Y Anraku, and
I Umezawa, and
S Omura
December 1985,
Chemical & pharmaceutical bulletin,
